ESBL

Ambler Class A Extended-Spectrum Beta-Lactamase-Producing Escherichia coli and Klebsiella spp. in Canadian Hospitals: American Society for Microbiology
This report describes a study carried out to gain baseline information on the molecular characteristics of extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli and Klebsiella spp. in Canada.
Emergence of Enterobacteriaceae producing extended-spectrum b-lactamases (ESBLs) in the community: Journal of Antimicrobial Chemotherapy Advance Access published May 25, 2005
This review indicates that ESBL-producing bacteria, especially E. coli producing CTX-M types, from community sources, have become widely prevalent in certain areas of the world and that they are most probably imported into the hospital setting.
Influx of Extended-Spectrum b-Lactamase– Producing Enterobacteriaceae into the Hospital: Chicago Journals
Excerpt:“"The prevalence of infections caused by extended-spectrum b-lactamase (ESBL)–producing Enterobacteriaceae is increasing worldwide. The influx of these bacteria into hospitals has major implications for infection-control and empirical treatment strategies." ”
Outbreaks of Multi-Drug Resistant Escherichia Coli in Long-Term Care Facilities in the Durham, York and Toronto Regions of Ontario, 2000 - 2002: Canada Communicable Disease Report - July 15, 2002 Volume 28 No. 14
This report describes the initial findings of an on-going investigation of related outbreaks of a clone of multi-drug resistant (MDR), extended spectrum beta-lactamase (ESBL)-producing Escherichia coli in long term care facilities in (LTCFs) in the Durham, York and Toronto Regions of Ontario. The purpose of this investigation is to determine the extent and cause of the outbreaks, identify contributing factors, institute control measures and evaluate their impact.
Risk Factors for Colonization with Extended-Spectrum β-Lactamase–producing Bacteria and Intensive Care Unit Admission: Emerging Infectious Diseases - Volume 13, Number 8–August 2007
Excerpt:“"In this study, we identified risk factors for ESBL-producing bacterial colonization among ICU patients. These data may be useful for identifying which patients may warrant empiric ESBL-targeted antimicrobial drug therapy. We also demonstrate that subsequent infections with ESBL-producing bacteria develop in a large percentage of ICU patients colonized with ESBL-producing bacteria." ”